Skip to main content
Erschienen in: Annals of Hematology 6/2013

01.06.2013 | Original Article

Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence—clinical implication and comparison between the West and the East

verfasst von: Shang-Ju Wu, Chien-Ting Lin, Sheng-Yi Huang, Fen-Yu Lee, Ming-Chi Liu, Hsin-An Hou, Chien-Yuan Chen, Bor-Sheng Ko, Wen-Chien Chou, Ming Yao, Jih-Luh Tang, Woei Tsay, Hwei-Fang Tien

Erschienen in: Annals of Hematology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Chronic lymphocytic leukemia (CLL) is much less prevalent in Taiwan than in the West, but we have recently addressed the distinctly increasing incidence of CLL in Taiwan. We sought to find out whether there is any difference in cytogenetic abnormalities (CA) of CLL between the West and the East. We analyze the CA, by conventional cytogenetics (CG) and fluorescence in situ hybridization (FISH), and their clinical significance in 83 Taiwanese CLL patients and compared the data to those of Western countries. Thirty-five patients (42.2 %) possessed CG-CA and 58 (69.9 %) FISH-CA. By either CG or FISH, deletion of 17p or 11q was associated with poorer overall survival (OS) (P < 0.001 and P = 0.008, respectively), whereas isolated 13q deletion was associated with better OS (P = 0.050). Trisomy 3 by CG was found in five patients; all of them were in Binet A stage but had strikingly poor OS (P < 0.001). This prognostic impact was independent from the other CA and Binet stages. We conclude that, though the disease incidence is much different, the CA of CLL in Taiwan are similar to those in the West. The combined CG and FISH analysis is able to predict the patients’ prognosis. The clinical significance of trisomy 3 warrants further validation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gatter KC, Warnke RA (2001) Chronic lymphocytic leukemia/small lymphocytic lymphoma. World Health Organization Classification of Tumors: tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon Gatter KC, Warnke RA (2001) Chronic lymphocytic leukemia/small lymphocytic lymphoma. World Health Organization Classification of Tumors: tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon
2.
Zurück zum Zitat Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48(1):198–206PubMedCrossRef Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48(1):198–206PubMedCrossRef
3.
Zurück zum Zitat Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46(2):219–234PubMed Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46(2):219–234PubMed
4.
Zurück zum Zitat Molica S, Alberti A (1987) Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer 60(11):2712–2716PubMedCrossRef Molica S, Alberti A (1987) Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer 60(11):2712–2716PubMedCrossRef
5.
Zurück zum Zitat Vinolas N, Reverter JC, Urbano-Ispizua A, Montserrat E, Rozman C (1987) Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance. Blood Cells 12(2):457–470PubMed Vinolas N, Reverter JC, Urbano-Ispizua A, Montserrat E, Rozman C (1987) Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance. Blood Cells 12(2):457–470PubMed
6.
Zurück zum Zitat Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94(6):1848–1854PubMed Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94(6):1848–1854PubMed
7.
Zurück zum Zitat Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101(12):4944–4951. doi:10.1182/blood-2002-10 PubMedCrossRef Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101(12):4944–4951. doi:10.​1182/​blood-2002-10 PubMedCrossRef
8.
Zurück zum Zitat Ghia P, Guida G, Stella S, Gottardi D, Geuna M, Strola G, Scielzo C, Caligaris-Cappio F (2003) The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 101(4):1262–1269. doi:10.1182/blood-2002-06-1801 PubMedCrossRef Ghia P, Guida G, Stella S, Gottardi D, Geuna M, Strola G, Scielzo C, Caligaris-Cappio F (2003) The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 101(4):1262–1269. doi:10.​1182/​blood-2002-06-1801 PubMedCrossRef
9.
10.
Zurück zum Zitat Johansson B, Mertens F, Mitelman F (1991) Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer 3(1):1–7PubMedCrossRef Johansson B, Mertens F, Mitelman F (1991) Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer 3(1):1–7PubMedCrossRef
11.
Zurück zum Zitat Tien HF, Wang CH, Lin MT, Lee FY, Liu MC, Chuang SM, Chen YC, Shen MC, Lin KH, Lin DT (1995) Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. Cancer Genet Cytogenet 84(1):60–68PubMedCrossRef Tien HF, Wang CH, Lin MT, Lee FY, Liu MC, Chuang SM, Chen YC, Shen MC, Lin KH, Lin DT (1995) Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. Cancer Genet Cytogenet 84(1):60–68PubMedCrossRef
12.
Zurück zum Zitat Chen CY, Yao M, Tang JL, Tsay W, Wang CC, Chou WC, Su IJ, Lee FY, Liu MC, Tien HF (2004) Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma. Ann Oncol 15(7):1091–1096. doi:10.1093/annonc/mdh263 PubMedCrossRef Chen CY, Yao M, Tang JL, Tsay W, Wang CC, Chou WC, Su IJ, Lee FY, Liu MC, Tien HF (2004) Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma. Ann Oncol 15(7):1091–1096. doi:10.​1093/​annonc/​mdh263 PubMedCrossRef
13.
Zurück zum Zitat Wu SJ, Huang SY, Lin CT, Lin YJ, Chang CJ, Tien HF The incidence of chronic lymphocytic leukemia in Taiwan, 1986–2005: a distinct increasing trend with birth-cohort effect. Blood 116 (22):4430–4435. doi:blood-2010-05-285221 [pii]10.1182/blood-2010-05-285221 Wu SJ, Huang SY, Lin CT, Lin YJ, Chang CJ, Tien HF The incidence of chronic lymphocytic leukemia in Taiwan, 1986–2005: a distinct increasing trend with birth-cohort effect. Blood 116 (22):4430–4435. doi:blood-2010-05-285221 [pii]10.​1182/​blood-2010-05-285221
14.
Zurück zum Zitat Chou WC, Tang JL, Lin LI, Yao M, Tsay W, Chen CY, Wu SJ, Huang CF, Chiou RJ, Tseng MH, Lin DT, Lin KH, Chen YC, Tien HF (2006) Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res 66(6):3310–3316. doi:10.1158/0008-5472.CAN-05-4316 PubMedCrossRef Chou WC, Tang JL, Lin LI, Yao M, Tsay W, Chen CY, Wu SJ, Huang CF, Chiou RJ, Tseng MH, Lin DT, Lin KH, Chen YC, Tien HF (2006) Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res 66(6):3310–3316. doi:10.​1158/​0008-5472.​CAN-05-4316 PubMedCrossRef
15.
Zurück zum Zitat Tien HF, Su IJ, Tang JL, Liu MC, Lee FY, Chen YC, Chuang SM (1997) Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. Br J Haematol 97(3):621–625PubMedCrossRef Tien HF, Su IJ, Tang JL, Liu MC, Lee FY, Chen YC, Chuang SM (1997) Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. Br J Haematol 97(3):621–625PubMedCrossRef
16.
Zurück zum Zitat Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T (2007) Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 21(12):2442–2451. doi:10.1038/sj.leu.2404935 PubMedCrossRef Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T (2007) Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 21(12):2442–2451. doi:10.​1038/​sj.​leu.​2404935 PubMedCrossRef
17.
Zurück zum Zitat Ko BS, Tang JL, Lee FY, Liu MC, Tsai W, Chen YC, Wang CH, Sheng MC, Lin DT, Lin KH, Tien HF (2002) Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Am J Hematol 71(4):291–299. doi:10.1002/ajh.10227 PubMedCrossRef Ko BS, Tang JL, Lee FY, Liu MC, Tsai W, Chen YC, Wang CH, Sheng MC, Lin DT, Lin KH, Tien HF (2002) Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Am J Hematol 71(4):291–299. doi:10.​1002/​ajh.​10227 PubMedCrossRef
18.
Zurück zum Zitat Huang SY, Yao M, Tang JL, Tsay W, Lee FY, Liu MC, Wang CH, Chen YC, Shen MC, Tien HF (2005) Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan. Ann Oncol 16(9):1530–1538. doi:10.1093/annonc/mdi273 PubMedCrossRef Huang SY, Yao M, Tang JL, Tsay W, Lee FY, Liu MC, Wang CH, Chen YC, Shen MC, Tien HF (2005) Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan. Ann Oncol 16(9):1530–1538. doi:10.​1093/​annonc/​mdi273 PubMedCrossRef
19.
Zurück zum Zitat Cuneo A, Rigolin GM, Bigoni R, De Angeli C, Veronese A, Cavazzini F, Bardi A, Roberti MG, Tammiso E, Agostini P, Ciccone M, Della Porta M, Tieghi A, Cavazzini L, Negrini M, Castoldi G (2004) Chronic lymphocytic leukemia with 6q − shows distinct hematological features and intermediate prognosis. Leukemia 18(3):476–483. doi:10.1038/sj.leu.24032422403242 PubMedCrossRef Cuneo A, Rigolin GM, Bigoni R, De Angeli C, Veronese A, Cavazzini F, Bardi A, Roberti MG, Tammiso E, Agostini P, Ciccone M, Della Porta M, Tieghi A, Cavazzini L, Negrini M, Castoldi G (2004) Chronic lymphocytic leukemia with 6q − shows distinct hematological features and intermediate prognosis. Leukemia 18(3):476–483. doi:10.​1038/​sj.​leu.​24032422403242 PubMedCrossRef
21.
23.
Zurück zum Zitat Qiu HX, Xu W, Cao XS, Zhou M, Shen YF, Xu YL, Sun XM, Liu Q, Wang R, Qiu HR, Wang JS, Li JY (2008) Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma 49(10):1887–1892. doi:10.1080/10428190802308710 PubMedCrossRef Qiu HX, Xu W, Cao XS, Zhou M, Shen YF, Xu YL, Sun XM, Liu Q, Wang R, Qiu HR, Wang JS, Li JY (2008) Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma 49(10):1887–1892. doi:10.​1080/​1042819080230871​0 PubMedCrossRef
24.
Zurück zum Zitat Shinohara T, Miwa S, Hasegawa S, Yamamoto K, Tonomura A (1988) Cytogenetic study of chronic lymphocytic leukemia in ten Japanese patients with a case of the same chromosome abnormality both in T and B cells. Cancer Genet Cytogenet 34(2):295–303PubMedCrossRef Shinohara T, Miwa S, Hasegawa S, Yamamoto K, Tonomura A (1988) Cytogenetic study of chronic lymphocytic leukemia in ten Japanese patients with a case of the same chromosome abnormality both in T and B cells. Cancer Genet Cytogenet 34(2):295–303PubMedCrossRef
25.
Zurück zum Zitat Chang YH, Park J, Kim HC, Chun HK, Kim YR, Kim M, Han K, Lee JH, Lee KH, Cho HI, Lee YS, Lee DS (2006) Korean patients with chronic lymphocytic leukemia show the similar types of chromosomal aberrations as those in Europe and North America. Leuk Res 30(6):695–699. doi:10.1016/j.leukres.2005.10.013 PubMedCrossRef Chang YH, Park J, Kim HC, Chun HK, Kim YR, Kim M, Han K, Lee JH, Lee KH, Cho HI, Lee YS, Lee DS (2006) Korean patients with chronic lymphocytic leukemia show the similar types of chromosomal aberrations as those in Europe and North America. Leuk Res 30(6):695–699. doi:10.​1016/​j.​leukres.​2005.​10.​013 PubMedCrossRef
26.
27.
Zurück zum Zitat Irons RD, Le A, Bao L, Zhu X, Ryder J, Wang XQ, Ji M, Chen Y, Wu X, Lin G (2009) Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns. Leuk Res 33(12):1599–1603. doi:10.1016/j.leukres.2008.12.021 PubMedCrossRef Irons RD, Le A, Bao L, Zhu X, Ryder J, Wang XQ, Ji M, Chen Y, Wu X, Lin G (2009) Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns. Leuk Res 33(12):1599–1603. doi:10.​1016/​j.​leukres.​2008.​12.​021 PubMedCrossRef
28.
Zurück zum Zitat Xu W, Cao X, Miao KR, Qiao C, Wu YJ, Liu Q, Fan L, Li JY (2009) Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Hematol 90(2):205–211. doi:10.1007/s12185-009-0380-8 PubMedCrossRef Xu W, Cao X, Miao KR, Qiao C, Wu YJ, Liu Q, Fan L, Li JY (2009) Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Hematol 90(2):205–211. doi:10.​1007/​s12185-009-0380-8 PubMedCrossRef
30.
Zurück zum Zitat Au WY, Fung A, Wong KF, Chan CH, Liang R (2006) Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leuk Lymphoma 47(10):2189–2193. doi:10.1080/10428190600758645 PubMedCrossRef Au WY, Fung A, Wong KF, Chan CH, Liang R (2006) Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leuk Lymphoma 47(10):2189–2193. doi:10.​1080/​1042819060075864​5 PubMedCrossRef
31.
Zurück zum Zitat Chen L, Li J, Zheng W, Zhang Y, Wu Y, Li L, Qian S, Xu W (2007) The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia. Leuk Lymphoma 48(9):1785–1792. doi:10.1080/10428190701534416 PubMedCrossRef Chen L, Li J, Zheng W, Zhang Y, Wu Y, Li L, Qian S, Xu W (2007) The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia. Leuk Lymphoma 48(9):1785–1792. doi:10.​1080/​1042819070153441​6 PubMedCrossRef
32.
Zurück zum Zitat Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Guneo A, Knuutila S et al (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323(11):720–724. doi:10.1056/NEJM199009133231105 PubMedCrossRef Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Guneo A, Knuutila S et al (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323(11):720–724. doi:10.​1056/​NEJM199009133231​105 PubMedCrossRef
33.
Zurück zum Zitat Grever MR, Lucas DM, Dewald GW, Neuberg DS, Reed JC, Kitada S, Flinn IW, Tallman MS, Appelbaum FR, Larson RA, Paietta E, Jelinek DF, Gribben JG, Byrd JC (2007) Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. J Clin Oncol 25(7):799–804. doi:10.1200/JCO.2006.08.3089 PubMedCrossRef Grever MR, Lucas DM, Dewald GW, Neuberg DS, Reed JC, Kitada S, Flinn IW, Tallman MS, Appelbaum FR, Larson RA, Paietta E, Jelinek DF, Gribben JG, Byrd JC (2007) Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. J Clin Oncol 25(7):799–804. doi:10.​1200/​JCO.​2006.​08.​3089 PubMedCrossRef
35.
Zurück zum Zitat Lu G, Kong Y, Yue C Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 196(1):56–63. doi:S0165-4608(09)00490-7 [pii]10.1016/j.cancergencyto.2009.08.021 Lu G, Kong Y, Yue C Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 196(1):56–63. doi:S0165-4608(09)00490-7 [pii]10.​1016/​j.​cancergencyto.​2009.​08.​021
36.
Zurück zum Zitat Krober A, Bloehdorn J, Hafner S, Buhler A, Seiler T, Kienle D, Winkler D, Bangerter M, Schlenk RF, Benner A, Lichter P, Dohner H, Stilgenbauer S (2006) Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J Clin Oncol 24(6):969–975. doi:10.1200/JCO.2005.03.7184 PubMedCrossRef Krober A, Bloehdorn J, Hafner S, Buhler A, Seiler T, Kienle D, Winkler D, Bangerter M, Schlenk RF, Benner A, Lichter P, Dohner H, Stilgenbauer S (2006) Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J Clin Oncol 24(6):969–975. doi:10.​1200/​JCO.​2005.​03.​7184 PubMedCrossRef
37.
Zurück zum Zitat Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, Dohner H, Stilgenbauer S (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100(4):1410–1416PubMed Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, Dohner H, Stilgenbauer S (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100(4):1410–1416PubMed
38.
Zurück zum Zitat Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GJ, Catovsky D (1996) Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 92(2):382–388PubMedCrossRef Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swansbury GJ, Catovsky D (1996) Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 92(2):382–388PubMedCrossRef
40.
Zurück zum Zitat Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK, Avet-Loiseau H (2004) Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64(4):1546–1558PubMedCrossRef Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK, Avet-Loiseau H (2004) Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64(4):1546–1558PubMedCrossRef
41.
Zurück zum Zitat Tsimberidou AM, Wen S, O'Brien S, McLaughlin P, Wierda WG, Ferrajoli A, Faderl S, Manning J, Lerner S, Mai CV, Rodriguez AM, Hess M, Do KA, Freireich EJ, Kantarjian HM, Medeiros LJ, Keating MJ (2007) Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. J Clin Oncol 25(29):4648–4656. doi:10.1200/JCO.2006.09.4508 PubMedCrossRef Tsimberidou AM, Wen S, O'Brien S, McLaughlin P, Wierda WG, Ferrajoli A, Faderl S, Manning J, Lerner S, Mai CV, Rodriguez AM, Hess M, Do KA, Freireich EJ, Kantarjian HM, Medeiros LJ, Keating MJ (2007) Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. J Clin Oncol 25(29):4648–4656. doi:10.​1200/​JCO.​2006.​09.​4508 PubMedCrossRef
42.
Zurück zum Zitat Krugmann J, Tzankov A, Dirnhofer S, Fend F, Wolf D, Siebert R, Probst P, Erdel M (2005) Complete or partial trisomy 3 in gastro-intestinal MALT lymphomas co-occurs with aberrations at 18q21 and correlates with advanced disease stage: a study on 25 cases. World J Gastroenterol 11(46):7384–7385PubMed Krugmann J, Tzankov A, Dirnhofer S, Fend F, Wolf D, Siebert R, Probst P, Erdel M (2005) Complete or partial trisomy 3 in gastro-intestinal MALT lymphomas co-occurs with aberrations at 18q21 and correlates with advanced disease stage: a study on 25 cases. World J Gastroenterol 11(46):7384–7385PubMed
43.
Zurück zum Zitat Taji S, Nomura K, Matsumoto Y, Sakabe H, Yoshida N, Mitsufuji S, Nishida K, Horiike S, Nakamura S, Morita M, Taniwaki M (2005) Trisomy 3 may predict a poor response of gastric MALT lymphoma to Helicobacter pylori eradication therapy. World J Gastroenterol 11(1):89–93PubMed Taji S, Nomura K, Matsumoto Y, Sakabe H, Yoshida N, Mitsufuji S, Nishida K, Horiike S, Nakamura S, Morita M, Taniwaki M (2005) Trisomy 3 may predict a poor response of gastric MALT lymphoma to Helicobacter pylori eradication therapy. World J Gastroenterol 11(1):89–93PubMed
44.
Zurück zum Zitat Wong KF, So CC, Chan JC, Kho BC, Chan JK (2002) Gain of chromosome 3/3q in B-cell chronic lymphoproliferative disorder is associated with plasmacytoid differentiation with or without IgM overproduction. Cancer Genet Cytogenet 136(1):82–85PubMedCrossRef Wong KF, So CC, Chan JC, Kho BC, Chan JK (2002) Gain of chromosome 3/3q in B-cell chronic lymphoproliferative disorder is associated with plasmacytoid differentiation with or without IgM overproduction. Cancer Genet Cytogenet 136(1):82–85PubMedCrossRef
Metadaten
Titel
Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence—clinical implication and comparison between the West and the East
verfasst von
Shang-Ju Wu
Chien-Ting Lin
Sheng-Yi Huang
Fen-Yu Lee
Ming-Chi Liu
Hsin-An Hou
Chien-Yuan Chen
Bor-Sheng Ko
Wen-Chien Chou
Ming Yao
Jih-Luh Tang
Woei Tsay
Hwei-Fang Tien
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 6/2013
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1700-x

Weitere Artikel der Ausgabe 6/2013

Annals of Hematology 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.